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While most patients affected by the influenza A(H1N1) pandemic experienced mild symp-
toms, a small fraction required hospitalization, often without concomitant factors that could
explain such a severe course. We hypothesize that host genetic factors could contribute to
aggravate the disease. To test this hypothesis, we compared the allele frequencies of
547,296 genome-wide single nucleotide polymorphisms (SNPs) between 49 severe and
107 mild confirmed influenza A cases, as well as against a general population sample of
549 individuals. When comparing severe vs. mild influenza A cases, only one SNP was
close to the conventional p = 5×10−8. This SNP, rs28454025, sits in an intron of the
GSK233 gene, which is involved in a neural development, but seems not to have any con-
nections with immunological or inflammatory functions. Indirectly, a previous association
reported with CD55 was replicated. Although sample sizes are low, we show that the statis-
tical power in our design was sufficient to detect highly-penetrant, quasi-Mendelian genetic
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factors. Hence, and assuming that rs28454025 is likely to be a false positive, no major
genetic factor was detected that could explain poor influenza A course.
Introduction
In 2009, the influenza A(H1N1)2009 pandemic swept the globe. Some of its features caused
concern, such as a higher mortality risk in infants and children than in seasonal influenza epi-
demics, and activity peaks out of the cold season. Although it followed a mild course in most
patients, in others it was much more aggressive for then unknown reasons. In Spain, a collec-
tion of severe, hospitalized patients was compared to a series of controls (defined as confirmed
but mild influenza cases that were treated ambulatorily), and a number of sociodemographic
and health risk factors were identified [1]. Yet, 37.2% of the severe cases showed no clinical or
sociodemographic risk factor for severe influenza.
Host genetic factors may be a contributor to influenza severity. Two genealogy studies in
Utah and Iceland clearly demonstrated familial aggregation of the risk of influenza-associated
death [2]. Albright et al. [3] compiled 4855 deaths due to influenza from a Utah database
between 1904 and 2004, and observed that the relative risk for relatives dying of influenza was
larger than for spouses. Thus, on top of the risk due to cohabitation and shared sociodemo-
graphic and environmental factors, the authors concluded that the risk of dying from influenza
is heritable. On the contrary, in the 1918 influenza epidemic in Iceland [4], the 455 deaths
showed no increased risk for the cases' relatives when compared to spouse's relatives. Notice
that the sample in the Icelandic study was an order of magnitude smaller than the Utah sample,
and its statistical power was presumably smaller.
Several studies have tackled human genetic variation in relation to influenza. A group of
candidate genes includes the pro-inflammatory cytokines and chemokines. Morales-García
et al.[5] compared Mexican influenza A patients and matching, co-inhabiting controls and
found that single nucleotide polymorphisms (SNPs) in the TNF and LTA genes contributed
to developing the disease, with an OR as high as 27 (95% CI 3–1248) for rs361525AA in
TNF. This allele was also found to be associated with influenza A in Greek patients, and in
particular with those developing pneumonia (OR 3.74, 95% CI 1.06–13.25)[6]. However, it
was not associated with fatal influenza (regardless of type, and accumulated over 10 influenza
seasons) in 105 US children and young adults [7]. Another candidate gene is the interferon-
inducible transmembrane protein IFITM3, which was shown to be essential against the influ-
enza A virus in mice in vivo. A sample of 53 severe UK patients showed higher frequencies of
the minor allele in an IFITM3 SNP, namely rs12252, compared to population databases com-
prising 3,000–9,000 individuals [8]. Moreover, genetic variation around this SNP revealed
the footprints of recent, positive natural selection in Europeans but not in Asians or Africans
[8].
A genome-wide association study (GWAS) indicated the complement regulatory protein
CD55 as a possible candidate for severe A influenza [9]; indeed, genotype rs2564978T/T in
CD55 showed an OR = 1.75 (P = 0.011) in 177 severe vs. 248 mild Chinese A(H1N1) cases
[9]. Finally, a GWAS was also performed in 91 severe Mexican patients vs. 98 exposed but
asymptomatic controls [10], by using an array designed for genes related with cardiovascu-
lar diseases. Four genome regions were identified as putative candidates to contribute to
infectivity and/or severity; these regions contained genes for the immunoglobulin-related
FCGR2A, the RPA interacting protein, and the complement-binding C1QBP protein, with
ORs up to 2.63.
A GWAS of A(H1N1)2009 Influenza Severity
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The goal of the present study is to explore the existence of major genetic determinants of
influenza A(H1N1) severity by comparing the genotypes of a dense array of genomewide SNPs
in 49 severe and 107 mild influenza patients from Spain, and in a general population sample of
549 individuals. To the best of our knowledge, this is the first attempt to analyze genetic factors
associated to influenza infection in a population of European ancestry.
Material and Methods
Samples
Cases were defined as confirmed influenza A(H1N1)2009 patients who had to be admitted to a
hospital. Genotypes were successfully obtained for 49 cases (27 from the Hospital Clínico de
Valladolid, 17 from Hospital Ramón y Cajal, Madrid, and 5 from Hospital Virgen del Camino,
Pamplona, all in Spain; 27 were women). Controls were also confirmed influenza patients with
mild symptoms who received ambulatory assistance; they were recruited as part of the Spanish
Influenza Case-Control Study cohort during the 2009–2010 first epidemic season of the new
virus. 107 controls (56 women) were successfully genotyped: 28 originated from the PIDIRAC
primary care influenza network in Catalonia, and 79 from the Red Centinela and Hospital
Clínico in Valencia. Additionally, a sample from the general population was used in some com-
parisons. It consisted of 549 DNA samples from subjects that self-reported having at least two
generations of ancestors born in Spain and without personal or familiar history of chronic dis-
eases. These individuals were obtained from the CeGen-PRB2-ISCIII project, and consisted of
unrelated healthy adult individuals collected from diverse geographic locations of Spain by
Fundacion Publica Galega de Medicina Xenomica. Appropriate written informed consent was
obtained from all participants in this study, which was approved by the Clinical Research Eth-
ics Committee-Parc de Salut Mar, Barcelona.
Influenza A virus detection and sample genotyping
Samples were divided into two aliquots to extract DNA and RNA separately. To extract DNA,
samples were first incubated for an hour with a lysis buffer plus proteinase K to digest the cells
membranes, followed by a standard phenol-chloroform purification and ethanol precipitation.
RNA was extracted by incubating first with TRIzol reagent (phenol/guanidine isothiocyanate),
then adding chloroform followed by a centrifugation step to recover the aqueous phase. We
then incubated this with isopropanol for an hour followed by centrifugation and ethanol wash.
Finally, the RNA pellet was diluted in RNase-free water. The WHO RT-PCR protocol [11] was
followed to confirm infection by influenza A (H1N1)2009 virus.Samples were genotyped with
the Affymetrix Axiom Genome-Wide Human CEU
Array, which contains 587,353 genome-wide SNPs and indels.
Statistical analyses
Genotypes were called with the Affymetrix Power Tools 1.14.4 provided by the manufacturer;
all samples were analyzed together to avoid array biases. A total of 156 samples (49 cases of
influenza A and 107 mild cases) passed the quality controls suggested by the manufacturer. In
addition, SNPs that failed in more than the 5% of samples were discarded, with 547,296 SNPs
remaining. Allele frequencies have been deposited in GWAS Central as study HGVST1832
(http://www.gwascentral.org/study/HGVST1832) and in the figshare repository (http://dx.doi.
org/10.6084/m9.figshare.1528227)
A genome-wide association study between severe and mild influenza cases was carried out
using the program Plink 1.07 [12]. In addition, 549 population samples from Galicia (NW
A GWAS of A(H1N1)2009 Influenza Severity
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Spain) were used as controls. The significance threshold for multiple test correction was set at
5×10−8, as suggested by [13]
Population stratification was estimated with two approaches: identity-by-state among indi-
viduals was computed with PLINK 1.07 and subsequently plotted with multidimensional scal-
ing. Independently, a Bayesian approach to population stratification with Admixture 1.22 [14]
was also used. Graphical representations of results were made using the R language [15]
Results
Population structure analysis using identity by state revealed a number of potential outliers:
eight samples of severe influenza, 17 cases of mild influenza, and eight controls (Fig 1), which
were removed from association analyses. ADMIXTURE analysis (S1 Fig) did not show any dis-
cernible pattern, and the optimal number of parental populations was K = 1, implying that
cases and controls can be considered as having been sampled from the same population.
The genome-wide association study between severe influenza A (41 cases) and mild influ-
enza A (90 cases) revealed one SNP (rs28454025) slightly above multiple-testing significance
level (unadjusted p = 5.595x10-8; the OR could not be computed since minor allele frequencies
were 0.1579 in cases but 0 in controls) as shown in Fig 2. This SNP is located in an intron of
Fig 1. Multidimensional scaling based on identity by state distances among severe influenza cases,
mild influenza cases, and a general population sample.
doi:10.1371/journal.pone.0135983.g001
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the SGK223 gene (homolog of rat pragma of Rnd2), which seems to regulate neurite
outgrowth.
In addition, 10 SNPs had p< 10−5 (S1 Table). Three of these SNPs were in introns of NAA-
LADL2 (N-acetylated alpha-linked acidic dipeptidase-like 2), at a maximum distance of 67.9
Kb between each other. This gene has been associated with, among other diseases, systemic
lupus erythematosus[16] and Kawasaki’s disease[17], both autoimmune disorders. Two other
SNPs were in introns ofMAML2 (mastermind-like 2 (Drosophila)), a member of the Notch
developmental pathway, and apparently unrelated to the immune function. We also found a
14-Kb block of 16 SNPs in the PARD3B gene (par-3 partitioning defective 3 homolog B (C. ele-
gans), involved in neurodevelopment) with p< 10−3. The SNPs in this block had odd ratios
between 2.1 and 2.9 and were ~1.4Mb downstream from CTLA4, a costimulatory molecule
expressed by activated T cells that has been linked to a number of autoimmune diseases.
Next, we considered a subset of SNPs that were in candidate genes that had been previously
associated with influenza A severity [8–10]. Unfortunately, none of the SNPs that had been
previously associated were in the array we genotyped; therefore, we selected the SNPs that were
Fig 2. Manhattan plot of severe vs. mild influenza cases. Only p-values < 0.05 are shown. The thick horizontal line denotes p = 5×10−8.
doi:10.1371/journal.pone.0135983.g002
A GWAS of A(H1N1)2009 Influenza Severity
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within 100 Kb of the previously associated SNPs. Note that we applied a hypothesis-specific
Bonferroni correction, taking into account the number of proxy SNPs (ranging from 2 to 52)
we found for each previously associated SNP IFITM3 is the gene that has been most consis-
tently associated with response to influenza A [8]; and, in particular, the rs12252 SNP. Our
array contained 27 SNPs in the vicinity, and only one, namely rs4131943, had a nominally sig-
nificant association with influenza A severity (p = 2.1×10−3, OR = 2.60 95% CI 1.40–4.83); note
that the hypothesis-specific number of tests was 27, and that the multiple testing correction
would yield p = 0.0567. For CD55 [9], within 100 Kb of the reported SNP, only two SNPs were
available in our array, one of which, rs2564978, was significantly associated with influenza
severity (p = 0.00638, OR = 7.11, 95% CI 1.4–36). Out of 11 SNPs in the vicinity of FCGR2A
[10], only one had a nominally significant association with influenza severity (rs7551957,
p = 0.0288), which did not survive Bonferroni correction. For the SNPs in the RPAIN-C1QBP
region, out of 52 SNPs in the vicinity, only two had p<0.05, with the smallest value (p = 0.0203,
corresponding to rs28447573, which was not the closest to any of the two previously associated
SNPs) far from surviving Bonferroni correction. In summary, we indirectly replicated the associ-
ation for CD55, that for IFITM3 was close to significance, and we could not indirectly replicate
the previous associations for FCGR2A, RPAIN, and C1QBP.
We also compared the two sets of influenza patients to the general population (S2–S4
Tables) and, given the larger sample size of the control population, more SNPs yielded signifi-
cant association tests (Fig 3). In the GWAS of severe influenza A against the general population
34 SNPs had p<5×10−8 and were in Hardy-Weinberg equilibrium (p> 0.05) (Fig 3A). In the
analysis of mild influenza A against the general population 35 SNPs (Fig 3B) met the same con-
ditions, and in the analysis of all influenza cases against the general population 14 SNPs had
significant differences (Fig 3C). Out of these SNPs, 31 were specific of severe influenza A cases
and 23 of mild influenza A cases (Fig 3D). The 34 SNPs detected in the comparison between
severe influenza cases and the general population comprised 16 intergenic SNPs, 14 intronic
SNPs, two synonymous SNPs, and two nonsynonymous SNPs: rs11551002 in gene APLP1
(amyloid precursor-like protein 1, involved in neural function), and rs11216131 in BUD13,
which participates in the regulation of serum lipid levels.
Next, we turned to the 49 genes that contained or were adjacent to the 34 SNPs with signifi-
cant differences between severe cases and the general population (S2 Table). We screened their
definitions in the Refseq database and their biological functions according to GO categories for
involvement in immunity and inflammation, and the Genetic Association Database and CDC
HuGe Published Literature for associations with autoimmune and inflammatory diseases. SNP
rs1996377 was 3.09 Mb downstream from DPP10, which is associated with asthma [18]; and
rs28447319 was 51.8 Kb upstream of B4GALT1, which is upregulated by proinflammatory
TNFα[19].
Discussion
In a GWAS for genetic contributors to the severity of influenza A infection, we did not find
any SNP with p<5×10−8; the SNP with the lowest p-value (and one order of magnitude smaller
than the next most associated SNP) was rs28454025, which lies in an intron of the SGK223
gene. This gene encodes an enzyme that belongs to the tyrosine protein kinase family. A similar
protein in rat binds to Rho family GTPase 2 (Rnd2) and regulates neurite outgrowth via activa-
tion of Ras homolog gene family, member A (RhoA) [20]. SNPs in SGK223 have only been
putatively associated with carotid artery disease[21], an association that has not been subse-
quently replicated. The association between rs28454025 and influenza A severity seems, then,
implausible.
A GWAS of A(H1N1)2009 Influenza Severity
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Previous studies had produced a number of SNPs that were associated with influenza infec-
tion or severity. None of those were contained in the array we genotyped, but, by using as prox-
ies SNPs in the genomic vicinity, we indirectly replicated the association with CD55, while
IFITM3 was close to statistical significance.
When we compared the severe influenza A cases with a much larger sample of the general
population, 34 SNPs had significant allele frequency differences (p<5×10−8) However, the bio-
logical plausibility of most of these associations was tenuous (e.g. SNPs with distances>100
Kb from the closest gene, or in or near genes with biological functions unlikely to be related to
inflammation or immunity).
Sample sizes in our study were low: 41 severe and 90 mild influenza A cases. Still, it has suf-
ficient statistical power to rule out common genetic variants as highly penetrant contributors
to poor prognosis in influenza A infection. The prevalence of severe influenza A among influ-
enza A cases without obvious risk factors was estimated as 0.26% in a Spanish population[22].
We used this figure and Genetic Power Calculator [23] to estimate that our study had 0.415
Fig 3. Manhattan plots of a general population sample vs. (A) severe influenza cases; (B) mild influenza cases and (C) all influenza cases. Only p-
values < 0.05 are shown. (D): Venn diagram of SNPs with significant associations with p<5×10−8 when comparing severe influenza cases, mild influenza
cases or all influenza cases to a general population sample.
doi:10.1371/journal.pone.0135983.g003
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power to detect a recessive variant with an allele frequency of 0.2 and an odds ratio of 25 with
α = 5×10−8 and a dominant model; for a recessive model, power increased to 0.805. Admit-
tedly, these parameters imply a penetrance sufficiently high so as that familial aggregation of
non-cohabiting relatives may have been observed. In particular, in these conditions the relative
risk for a sibling would be 1.562 in the dominant model and 2.404 in the recessive model.
In conclusion, our study did not detect what was powered to find, namely one or a few host
genes with a major impact in poor influenza course. However, this does not rule out the pres-
ence of genes with a more limited contribution.
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